Diabetes poses a significant public health concern, impacting around 828 million individuals worldwide. Concurrently, oral health issues, including dental caries, periodontal diseases, and oral cancers, affect nearly 3.7 billion people globally. There exists a hypothesis suggesting potential interactions between poor diabetes management and oral health, urging the need for comprehensive studies to explore these associations further.
This investigation performed a systematic review and meta-analysis following PRISMA guidelines. The research encompassed a thorough search through four electronic databases (Embase, PubMed, Web of Science, and LILACS) as well as grey literature up until October 27, 2025. Criteria for inclusion focused on longitudinal studies assessing associations between diabetes (types 1, 2, gestational) and WHO core oral diseases: periodontitis, dental caries, tooth loss (edentalism), and oral cancer. Pooled effect sizes were calculated using random-effects meta-analyses to determine hazard ratios (HR) and risk ratios (RR).
A total of 45,477 records were screened, leading to the inclusion of 28 longitudinal studies from 16 countries, which gathered data from over 300,000 participants. These studies primarily exhibit moderate to high methodological quality. The analysis indicated a bidirectional relationship, particularly strong between diabetes and periodontitis. Individuals presenting with periodontitis displayed an 18-25% heightened likelihood of experiencing new cases of type 2 diabetes. Conversely, baseline diabetes status corresponded with an increased incidence of periodontitis, evidenced by pooled RRs, albeit with modest differences. Tooth loss was similarly associated with newly diagnosed type 2 diabetes (HR 1.12–1.20). However, no quantitative analysis could be performed for edentulism; though participants with edentulism at baseline indicated a significant likelihood of developing new diabetes cases (RR 1.30). Evidence surrounding dental caries was inconsistent and insufficient for meta-analysis, while no longitudinal data for oral cancer was identified.
The results illustrate a significant bidirectional relationship between diabetes and oral diseases, predominantly periodontitis. Individuals with periodontitis may face increased diabetes diagnosis risks, while those diagnosed with diabetes exhibit a considerable likelihood of developing periodontitis, though the evidence's strength varies. These insights underscore the necessity for integrating oral health in diabetes care frameworks to improve outcomes substantially.
Currently, diabetes impacts over 828 million adults globally, a number expected to rise to 1.3 billion by 2050. This condition frequently results in multiple chronic complications, among which oral diseases have been identified as critical yet often overlooked issues. Despite growing acknowledgment of the links between diabetes and oral health, research findings remain sporadic and lack coherence due to varying study conditions and methodologies.
Earlier studies have shown the link between diabetes and oral health issues such as periodontitis, yet consistently unreliable evidence persists due to methodological variances. Investigating through established databases has allowed for a structured collection of relevant data, focusing on the bidirectional relationship between diabetes and oral health outcomes.
This systematic review stands out as the first comprehensive aggregation of longitudinal evidence concerning core WHO oral health outcomes. The studies investigated not just one pathway but the intertwining risks between diabetes and periodontitis, tooth loss, and how these factors interact with one another over time.
The findings suggest that integrated approaches involving oral health professionals are crucial for monitoring and managing both diabetes and oral health concurrently. Recognizing the tight linkage between periodontitis diagnosis and diabetes can help healthcare providers implement more effective early assessments and preventive strategies moving forward, reducing complications associated with both conditions.
The established protocol adhered to PRISMA-P guidelines to ensure rigorous investigation controls were in place. Eligibility was strictly confined to longitudinal studies covering the comprehensive WHO oral disease outcomes. This strategy ensures more robust evidence reflecting the temporal dynamics between oral health and diabetes.
Only prospective studies examining the sequential effects of diabetes on oral health or vice versa were accepted. This methodology mitigates reverse causation risks prevalent in retrospective studies, ensuring more precise results.
Research was conducted across multiple databases and incorporated grey literature as an essential source, adhering to rigorous standards throughout the search and selection process. The method ensured a diverse array of studies to fortify the investigation's robustness.
Data were systematically gathered by multiple reviewers to achieve an unbiased representation of findings, ultimately leading to rigorous conclusions about the relationship between diabetes and oral diseases.
Study quality assessments involved the Newcastle-Ottawa Scale, with rigorous checks to categorize studies according to their bias risks, reflecting the reliability of the gathered evidence.
A collection of evidence tables facilitated a comprehensive synthesis of findings, employing meta-analytical techniques to reveal strong trends while assessing inconsistencies across studies effectively.
Following a systematic elimination process of duplicates and irrelevant studies, the final output consisted of 28 longitudinal studies enhancing our understanding of the interconnectedness of diabetes and oral health outcomes, ultimately advocating for interdisciplinary management strategies.